Commits to Thoracic Society’s COVID-19 Fund
Boehringer Ingelheim is committing USD 500,000 (around EUR 458,000) to the American Thoracic Society (ATS) and its COVID-19 Crisis Fund. Learn more here.
Search
COVID-19: Research Update
Boehringer Ingelheim stops treatment with experimental medication in study investigating benefits for severely ill patients with COVID-19. Learn more.
COVID-19 France Support to Pasteur Institute
As part of our Global Donation Program, we are supporting research on COVID-19 in France. Click here to learn more information about the support.
COVID-19 Once a nurse always a nurse
Colleagues Anne Hunstad and Maarten van Helvoirt, both educated nurses, support the health care workers during the COVID-19 pandemic. Learn more.
COVID-19 Spain - Volunteering for good causes in Spain
Three Boehringer Ingelheim employees in Spain have stepped forward to help out during the COVID-19 pandemic. Click here to find out and learn more.
COVID-19 Joining forces against COVID-19
While the challenges posed by the COVID-19 pandemic are massive, so are the good examples of corporate citizenship arising all over the world. Learn more.
COVID-19 Global Access Commitment with Gates Foundation
Boehringer Ingelheim commits to provide global access to COVID-19 therapeutics by signing a communiqué with the Bill & Melinda Gates Foundation.
COVID-19 Czech Republic – Supporting hospitals, hippotherapy
We decided to support local Czech hospitals with a donation of 1.15 million CZK (42.000 EURO) to help them fight COVID-19. Click here to learn more.
COVID-19 Italy for isolated patients to keep contact
300 tablets donated to hospitals in Italy where patients isolated due to COVID-19 are fighting for recovery to let them feel less alone. Learn more here.
COVID-19 Protecting Our Employees
We have taken precautions to protect our employees health and mitigate the risk of COVID-19 affecting our organisation. Click here to find out more.
COVID-19 Volunteering in Australia and New Zealand
Our employees down under have embraced the opportunity to volunteer their time and skills as part of the company’s COVID-19 Global Support Program.
COVID-19 Boehringer Ingelheim Thailand equips frontline
Boehringer Ingelheim Thailand is working together with the Thai Department of Disease Control during the pandemic. Click here to learn more.
COVID-19 Germany Together through the Pandemic
Boehringer Ingelheim enabled all 51,000 employees worldwide to take ten days off for voluntary work – with full payment. Click here to learn more.
Coronavirus in pets and humans: learn the differences
Coronavirus in pets and humans: learn the differences. To date, there is no evidence that dogs and cats can be infected or transmit COVID-19.
Stroke, Don’t Stay at Home
During COVID-19, there was a decrease in stroke hospital admissions. Learn why it is crucial that patients can still access urgent care at this time.
COVID-19 Relief Efforts in China
Since the outbreak of the Coronavirus disease in China in late January, Boehringer Ingelheim has quickly decided to make a number of donations. Read more.
Healthcare professionals
Faced with COVID-19, everyone has to adjust their lives, which can be challenging. This is especially true for healthcare professionals. Find out more.
COVID-19 Spain pulse oximeters donation
Boehringer Ingelheim Spain has contributed to the COVIDALARM project by financing the purchase of 200 intelligent pulse oximeters. Learn more here.
COVID-19 Social distancing and pet care - A vet gives advice
We have asked Karsten Hesse, Technical Service Manager Pet at Boehringer Ingelheim from Germany, about the topic of social distancing and pet care.
COVID-19 RCV thank you
A big thank you to all doctors, all nurses and all others working in the healthcare sector from the employees of BI Regional Centre Vienna. Read more here!
COVID-19: EFPIA Industry Information
The EFPIA and its member companies and associations are committed to the global fight against the coronavirus pandemic. Click here to learn more.
COVID-19 IMI2–Call 21
CARE launched to accelerate therapy development against COVID-19 and future coronavirus threats.
COVID-19 Q&A for people with chronic respiratory conditions
Here you can find a summary of COVID-19 advice for those with chronic respiratory conditions. Click here to read the questions and answers and learn more.
COVID-19 Bill and Melinda Gates Foundation
We are joining the COVID-19 Therapeutics Accelerator of the Bill and Melinda Gates Foundation to fight the pandemic. Click here to learn more.
COVID-19 Q&A for people with diabetes
Here you can find a summary of COVID-19 advice for patients with diabetes. Click here to read the questions and answers to find out more information.